Papers/PMID:38232906
Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.
Complementary therapies in medicine2024The record
6 findings drawn from this paper, on 1 compound across 6 endpoints, 6 of them null.
What it reported
How to read these marksEvery finding here is a null result.
What did not
6 findings
curcumin — no detected effect on glycated haemoglobin (HbA1c)
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull resultreplicated ×2“There was no significant change in HbA1C, plasma insulin, QUICKI, HDL, SBP, DBP, CRP, TNF-α and WC after curcumin therapy.”
Quoted verbatim from Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Population
- adults with non-alcoholic fatty liver disease (NAFLD)
curcumin — no detected effect on tumour necrosis factor alpha concentration
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull resultreplicated ×2“There was no significant change in HbA1C, plasma insulin, QUICKI, HDL, SBP, DBP, CRP, TNF-α and WC after curcumin therapy.”
Quoted verbatim from Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Population
- adults with non-alcoholic fatty liver disease (NAFLD)
curcumin — no detected effect on HDL cholesterol
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull resultreplicated ×2“There was no significant change in HbA1C, plasma insulin, QUICKI, HDL, SBP, DBP, CRP, TNF-α and WC after curcumin therapy.”
Quoted verbatim from Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Population
- adults with non-alcoholic fatty liver disease (NAFLD)
curcumin — no detected effect on systolic blood pressure (setting unspecified)
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull resultreplicated ×2“There was no significant change in HbA1C, plasma insulin, QUICKI, HDL, SBP, DBP, CRP, TNF-α and WC after curcumin therapy.”
Quoted verbatim from Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Population
- adults with non-alcoholic fatty liver disease (NAFLD)
curcumin — no detected effect on diastolic blood pressure (setting unspecified)
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull resultreplicated ×2“There was no significant change in HbA1C, plasma insulin, QUICKI, HDL, SBP, DBP, CRP, TNF-α and WC after curcumin therapy.”
Quoted verbatim from Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Population
- adults with non-alcoholic fatty liver disease (NAFLD)
curcumin — no detected effect on C-reactive protein concentration
PreliminaryGrade D, Preliminary. Non-human or in vitro only.FindingNull resultreplicated ×1“There was no significant change in HbA1C, plasma insulin, QUICKI, HDL, SBP, DBP, CRP, TNF-α and WC after curcumin therapy.”
Quoted verbatim from Curcumin effects on glycaemic indices, lipid profile, blood pressure, inflammatory markers and anthropometric measurements of non-alcoholic fatty liver disease patients: A systematic review and meta-analysis of randomized clinical trials.. - Study
- meta-analysis
- Population
- adults with non-alcoholic fatty liver disease (NAFLD)